date,title,source
Oct-22-18,Here's Why Kura Oncology Fell Today,Motley Fool
Oct-22-18,Kura Oncology Presents Update on Positive Phase 2 Trial of Tipifarnib in HRAS Mutant HNSCC and Preliminary Results in HRAS Mutant SCC,GlobeNewswire
